(S (NP (NP (NNS Patients)) (VP (VBN affected) (PP (IN by) (NP (DT this) (NN disease))))) (VP (MD can) (VP (VB be) (VP (VBN treated) (PP (IN with) (NP (NP (DT the) (NN help)) (PP (IN of) (NP (NP (NNS medicines)) (CC or) (NP (JJ surgical) (NNS procedures))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (NP (DT both)) (PP (IN of) (NP (DT these) (NNS methods)))) (VP (VBP are) (RB not) (ADJP (RB quite) (JJ useful))) (. .))
(S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (SBAR (IN that) (S (NP (NP (JJ abnormal) (NN activity)) (PP (IN in) (NP (DT the) (NN brain) (NNS signals)))) (VP (VBZ starts) (PP (IN before) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (NN seizure)) (VP (VBN known) (PP (IN as) (NP (DT the) (JJ preictal) (NN state)))))))))))))) (. .))
(S (S (NP (PRP We)) (VP (VBP have) (VP (VBN applied) (NP (PRP$ our) (NN model)) (PP (IN on) (NP (CD 23) (NNS subjects)))))) (CC and) (S (NP (NP (DT an) (JJ average) (NN sensitivity)) (PP (IN of) (NP (CD 93.1) (NN %)))) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (IN for) (NP (CD 84) (NNS seizures))))))) (. .))
